|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.305
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.289
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.282
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.257
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.254
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.234
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.227
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.224
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.188
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.166
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.162
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.148
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.143
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.138
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.132
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.129
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.128
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.128
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.127
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.119
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.116
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.115
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.114
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.112
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.107
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.107
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.107
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.106
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.103
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.097
|
|
|
|
pirna metabolic process
|
GO:0034587 |
12 |
0.096
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.096
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.094
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.092
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.091
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.089
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.083
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.083
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.080
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.080
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.079
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.079
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.077
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.075
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.074
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.074
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.072
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.072
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.072
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.071
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.071
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.071
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.069
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.068
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.067
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.067
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.067
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.066
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.065
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.063
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.063
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.062
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.062
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.062
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.062
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.061
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.060
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.060
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.058
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.058
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.057
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.057
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.057
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.056
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.056
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.056
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.055
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.055
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.054
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.053
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.053
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.053
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.053
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.053
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.052
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.052
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.052
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.051
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.051
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.050
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.050
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.050
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.050
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.050
|
|
|
|
neuron fate specification
|
GO:0048665 |
30 |
0.050
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.049
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.049
|
|
|
|
type b pancreatic cell fate commitment
|
GO:0003327 |
1 |
0.049
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.048
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.048
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.048
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.048
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.048
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.048
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.047
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.046
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.045
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.045
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.045
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.045
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.044
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.044
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.044
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.044
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.043
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.043
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.043
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.043
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.043
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.043
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.042
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.042
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.042
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.042
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.042
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.042
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.042
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.042
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.042
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.042
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.041
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.041
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.041
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.041
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.040
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.040
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.040
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.040
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.040
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.040
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.039
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.039
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.039
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.039
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.039
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.039
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.038
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.038
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.038
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.038
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.038
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.037
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.037
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.037
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.037
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.037
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.037
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.037
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.037
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.037
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.037
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.037
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.037
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.037
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.036
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.036
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.036
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.036
|
|
|
|
horizontal cell localization
|
GO:0035852 |
1 |
0.036
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.036
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.036
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.036
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.036
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.036
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.036
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.036
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.036
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.036
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.036
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.035
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.035
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.035
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.035
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.035
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.035
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.035
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.035
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.034
|
|
|
|
retinal bipolar neuron differentiation
|
GO:0060040 |
5 |
0.034
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.034
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.034
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.034
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.034
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.034
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.034
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.034
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.034
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.034
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.034
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.034
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.034
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.033
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.033
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.033
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.033
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.033
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.033
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.033
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.032
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
cardiac epithelial to mesenchymal transition
|
GO:0060317 |
18 |
0.032
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.032
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.032
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.032
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.032
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.031
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.031
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.031
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.031
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
positive regulation of sodium ion transport
|
GO:0010765 |
13 |
0.031
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.030
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.030
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.030
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.030
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.030
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.030
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.030
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.030
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.030
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.029
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.029
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.029
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.029
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.029
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.029
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.029
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.029
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.029
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.029
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.029
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.029
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.029
|
|
|
|
negative regulation of mesodermal cell fate specification
|
GO:0042662 |
3 |
0.028
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.028
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.028
|
|
|
|
granulocyte colony stimulating factor production
|
GO:0071611 |
1 |
0.028
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.028
|
|
|
|
lung pattern specification process
|
GO:0060432 |
1 |
0.028
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.028
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.028
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.028
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.028
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.028
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.028
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.028
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.028
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.028
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.028
|
|
|
|
cerebral cortex gabaergic interneuron differentiation
|
GO:0021892 |
9 |
0.028
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.028
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.028
|
|
|
|
heart induction
|
GO:0003129 |
2 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.027
|
|
|
|
columnar cuboidal epithelial cell development
|
GO:0002066 |
29 |
0.027
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.027
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.027
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.027
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.027
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.027
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.027
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.027
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.027
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.027
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.027
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.027
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.027
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.026
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
Fly |
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.026
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.026
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.026
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.026
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.026
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.026
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.026
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.026
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.026
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.026
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.026
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.026
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.025
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.025
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.025
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.025
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.025
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.025
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.025
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.025
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.025
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.025
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.025
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.025
|
|
|
|
t helper 17 cell lineage commitment
|
GO:0072540 |
4 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.025
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.025
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.024
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.024
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.024
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.024
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.024
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.024
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.024
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.024
|
|
|
|
pharyngeal system development
|
GO:0060037 |
17 |
0.024
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.024
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.024
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
18 |
0.023
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.023
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.023
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.023
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.023
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.023
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.023
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.023
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.023
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.023
|
|
|
|
cochlea morphogenesis
|
GO:0090103 |
22 |
0.023
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.023
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.023
|
|
|
|
medial motor column neuron differentiation
|
GO:0021526 |
2 |
0.023
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.023
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.022
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.022
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.022
|
|
|
|
macrophage colony stimulating factor production
|
GO:0036301 |
1 |
0.022
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.022
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.022
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.022
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.022
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.022
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.022
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.022
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.022
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.022
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.022
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.022
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.021
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.021
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.021
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.021
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.021
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.021
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.021
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.021
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.021
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.021
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.021
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.021
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.021
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.021
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.021
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.021
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.020
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.020
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.020
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.020
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.020
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.020
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.020
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.020
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.020
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.020
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.020
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.019
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.019
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.019
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.019
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
27 |
0.019
|
|
|
|
negative regulation of transposition
|
GO:0010529 |
2 |
0.019
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.019
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.019
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.019
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.019
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
oligodendrocyte development
|
GO:0014003 |
20 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.019
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.019
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.019
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.019
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.019
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.019
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.019
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.019
|
|
|
|
positive regulation of glial cell differentiation
|
GO:0045687 |
21 |
0.019
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.018
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.018
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.018
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.018
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.018
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.018
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.018
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.018
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.018
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.018
|
|
|
|
regulation of cerebellar granule cell precursor proliferation
|
GO:0021936 |
12 |
0.018
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.018
|
|
|
|
granulocyte macrophage colony stimulating factor production
|
GO:0032604 |
3 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.018
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.018
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.018
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.017
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.017
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.017
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.017
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.017
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.017
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.017
|
|
|
|
regulation of heart induction by regulation of canonical wnt signaling pathway
|
GO:0090081 |
2 |
0.017
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.017
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.017
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.017
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.017
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.017
|
|
